Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

The Form 4 shows shares purchased by GC on line 1. Line 2 shows indirect ownership of shares awarded to Amarantus in the acquisition of the Breakthrough Diagnostics subsidiary and the LymPro test in June 2020.

Line 2 does not indicate shares purchased. Notice there is no transaction date or transaction code. It is included to show the Todos shares owned by Amarantus over which GC has voting rights (in addition to the shares just purchased on line 1).